OTC · EMMA
Emmaus Life Sciences, Inc.
$0.04-$0.00 (-12.0%)
Emmaus Life Sciences, Inc.’s quoted price sits in the lower half of its reported 52-week range, 59.95% below the high.
Loading market information…
OTC · SYBE · USD
Stock price
Quote as of Oct 28, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
SYBLEU Inc’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
Established in 2020, SYBLEU Inc. specializes in developing regenerative medical applications. The firm's headquarters are located in Bronx, New York.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 03:41 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
KEEP COMPARING
$0.04-$0.00 (-12.0%)
Emmaus Life Sciences, Inc.’s quoted price sits in the lower half of its reported 52-week range, 59.95% below the high.
A$0.00A$0.00 (0.0%)
Biotron Limited’s quoted price sits in the lower half of its reported 52-week range, 60.0% below the high.
$0.00-$0.00 (-11.11%)
Premier Graphene, Inc.’s quoted price sits in the lower half of its reported 52-week range, 60.0% below the high.
€0.03-€0.00 (-1.47%)
Biophytis S.A.’s quoted price sits in the lower half of its reported 52-week range, 79.12% below the high.
$3.29$0.00 (0.0%)
Helix BioMedix, Inc.’s quoted price sits in the lower half of its reported 52-week range, 49.38% below the high.
$0.02$0.00 (0.0%)
SQZ Biotechnologies Company’s quoted price sits in the lower half of its reported 52-week range, 65.71% below the high.
$0.00$0.00 (0.0%)
Justera Health Ltd.: Technology · Software - Application.
$0.00$0.00 (0.0%)
Viropro Inc.’s quoted price sits in the lower half of its reported 52-week range, 80.0% below the high.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
